Craft

Advanced
Codexis

Codexis

Stock Price

$3.2

2024-10-29

Market Capitalization

$226.3 M

2024-10-29

Revenue

$70.4 M

FY, 2025

Codexis Summary

Company Summary

Overview
Codexis is a protein engineering company that develops enzymes for pharmaceutical, food, and medical applications. Its Performance Enzymes segment enables bioprocesses for cost and sustainable pharmaceutical manufacturing.
Type
Public
Status
Active
Founded
2002
HQ
Redwood City, CA, US | view all locations
Website
https://www.codexis.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Stephen Dilly

    Stephen Dilly, President & Chief Executive Officer, Director

  • Byron Dorgan
  • David V. Smith

    David V. Smith, Director

    • Jennifer Aaker

    LocationsView all

    1 location detected

    • Redwood City, CA HQ

      United States

      200 Penobscot Drive

    Codexis Financials

    Summary Financials

    Revenue (Q1, 2026)
    $15.2M
    Gross profit (Q1, 2026)
    $13.2M
    Net income (Q1, 2026)
    ($8.7M)
    Cash (Q1, 2026)
    $36.6M
    EBIT (Q1, 2026)
    ($8.0M)
    Enterprise value
    $262.6M

    Competitors and Similar Companies

    Compare competitors

    Footer menu

    Product

    Solutions

    Resources

    Company

    © Craft.co 2026
    Share price data provided by IEX